Cargando…

Effects of Spironolactone on Arrhythmias in Hemodialysis Patients: Secondary Results of the SPin-D Randomized Controlled Trial

KEY POINTS: The effects of spironolactone on arrhythmia in patients receiving maintenance hemodialysis are unclear. In these post hoc analyses, spironolactone resulted in a higher frequency of bradycardia and conduction blocks, compared with placebo. Close monitoring may be warranted for patients on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mc Causland, Finnian R., Hsu, Jesse Y., Himmelfarb, Jonathan, Ikizler, Talat Alp, Raj, Dominic S., Mehrotra, Rajnish, Waikar, Sushrut S., Kimmel, Paul L., Kliger, Alan S., Dember, Laura M., Charytan, David M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Nephrology 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10278797/ https://www.ncbi.nlm.nih.gov/pubmed/36763641 http://dx.doi.org/10.34067/KID.0000000000000067

Ejemplares similares

Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients
por: Rivara, Matthew B., et al.
Publicado: (2015)

Spironolactone and Cardiac Arrhythmias in Hemodialysis Patients: Helpful or Harmful?
por: Pun, Patrick H.
Publicado: (2023)

Minimizing the risk of COVID-19 among patients on dialysis
por: Ikizler, T. Alp, et al.
Publicado: (2020)

The Association of Ejection Fraction With Hospital-Associated Cardiac Arrest and Heart Failure Hospitalization Differs According to Baseline Estimated GFR
por: Ravi, Katherine Scovner, et al.
Publicado: (2023)

Managing the COVID-19 pandemic: international comparisons in dialysis patients
por: Kliger, Alan S., et al.
Publicado: (2020)

Performance of a brief survey to assess health literacy in patients receiving hemodialysis
por: Cavanaugh, Kerri L., et al.
Publicado: (2015)

COVID-19 Infection Risk Among Hemodialysis Patients in Long-term Care Facilities
por: Liu, Christine K., et al.
Publicado: (2020)

Spironolactone as a Potential New Treatment to Prevent Arrhythmias in Arrhythmogenic Cardiomyopathy Cell Model
por: Reisqs, Jean-Baptiste, et al.
Publicado: (2023)

Relationship between dialytic parameters and reviewer confirmed arrhythmias in hemodialysis patients in the monitoring in dialysis study
por: Tumlin, James A., et al.
Publicado: (2019)

A Systematic Review of the Incidence of Arrhythmias in Hemodialysis Patients Undergoing Long-Term Monitoring With Implantable Loop Recorders
por: Roberts, Paul R., et al.
Publicado: (2020)

Coenzyme Q(10) dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
por: Yeung, Catherine K., et al.
Publicado: (2015)

Effect of spironolactone on vascular stiffness in hemodialysis patients: a randomized crossover trial
por: Eklund, Michael, et al.
Publicado: (2022)

The current and future landscape of dialysis
por: Himmelfarb, Jonathan, et al.
Publicado: (2020)

Fibroblast Growth Factor 23 and Muscle Wasting: A Metabolic Point of View
por: Elsurer Afsar, Rengin, et al.
Publicado: (2023)

Response to “Use of Oral Furosemide in Hemodialysis”
por: Flythe, Jennifer E., et al.
Publicado: (2022)

Research Progress on the Efficacy and Safety of Spironolactone in Reversing Left Ventricular Hypertrophy in Hemodialysis Patients
por: Sun, Zuoya, et al.
Publicado: (2023)

Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan
por: Makhlough, Atieh, et al.
Publicado: (2014)

Acute Kidney Injury and Advanced Kidney Disease in the COVID-19 Pandemic: Proceedings From a National Kidney Foundation Symposium
por: Hirsch, Jamie S., et al.
Publicado: (2021)

Structural and Psychosocial Challenges Among Underserved Patients Receiving Hemodialysis During and Beyond the COVID-19 Pandemic: A Qualitative Study
por: Shohet, Merav, et al.
Publicado: (2023)

The COVID-19 infection in dialysis: are home-based renal replacement therapies a way to improve patient management?
por: Cozzolino, Mario, et al.
Publicado: (2020)

Safety evaluation and cardiovascular effect of additional use of spironolactone in hemodialysis patients: a meta-analysis
por: Zeng, Qing, et al.
Publicado: (2019)

Tissue sodium accumulation and peripheral insulin sensitivity in maintenance hemodialysis patients
por: Deger, Serpil Muge, et al.
Publicado: (2017)

Ferric pyrophosphate citrate administered via dialysate reduces erythropoiesis-stimulating agent use and maintains hemoglobin in hemodialysis patients
por: Gupta, Ajay, et al.
Publicado: (2015)

Assessment of arterial stiffness using pulse wave velocity in tacrolimus users the first year post kidney transplantation: a prospective cohort study
por: Birdwell, Kelly Ann, et al.
Publicado: (2015)

Spironolactone-Induced Unilateral Gynecomastia
por: Veeregowda, Sahana Hadihalli, et al.
Publicado: (2018)

Angiotensin converting enzyme inhibition increases ADMA concentration in patients on maintenance hemodialysis – a randomized cross-over study
por: Gamboa, Jorge L., et al.
Publicado: (2015)

Time to Expand Access and Utilization of Home Dialysis: Lessons From the COVID-19 Pandemic
por: Stern, Lauren D., et al.
Publicado: (2020)

4164 Body mass index, not chemotherapy is the major predictor of insulin resistance in patients with hematological malignancies
por: Sahinoz, Melis, et al.
Publicado: (2020)

Safety of Low-Protein Diets and Ketoanalogue Supplementation in CKD
por: Ikizler, T. Alp
Publicado: (2018)

COVID-19 in dialysis patients: adding a few more pieces to the puzzle
por: Ikizler, T. Alp
Publicado: (2020)

COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?
por: Ikizler, T. Alp
Publicado: (2020)

Sepsis as a cause and consequence of acute kidney injury: Program to Improve Care in Acute Renal Disease
por: Mehta, Ravindra L., et al.
Publicado: (2010)

Performance of the Automated Urinalysis in Diagnosis of Proliferative Glomerulonephritis
por: Palsson, Ragnar, et al.
Publicado: (2019)

Evaluating the feasibility of the KDIGO CKD referral recommendations
por: Singh, Karandeep, et al.
Publicado: (2017)

Effect of spironolactone on pain responses in mice
por: Abdel-Salam, Omar M.E., et al.
Publicado: (2010)

Spironolactone in cardiovascular disease: an expanding universe?
por: Funder, John W.
Publicado: (2017)

Imatinib and spironolactone suppress hepcidin expression
por: Mleczko-Sanecka, Katarzyna, et al.
Publicado: (2017)

Furosemide/spironolactone: Hypotension: case report
Publicado: (2022)

Erratum to: Wasting in chronic kidney disease
por: Mak, Robert H., et al.
Publicado: (2011)

Wasting in chronic kidney disease
por: Mak, Robert H., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p4qj824djudcil3jfoadjtaa7u